Henoch-Schönlein purpura in children

Journal of Paediatrics and Child Health

Volumn 49, Issue 12, 2013, Pages 995-1003

  Trnka, Peter ^a  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

chronic kidney disease; immunoglobulin A; nephritis; purpura; vasculitis

Indexed keywords

ABDOMINAL PAIN; ANAPHYLACTOID PURPURA; ARTHRALGIA; ARTHRITIS; BLOOD ANALYSIS; CHILDHOOD DISEASE; CHRONIC KIDNEY DISEASE; CLINICAL FEATURE; DIAGNOSTIC IMAGING; DISEASE CLASSIFICATION; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DISEASE; LONG TERM CARE; OUTCOME ASSESSMENT; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; PURPURA; REVIEW; SYSTEMIC VASCULITIS; URINALYSIS;

CHRONIC KIDNEY DISEASE; IMMUNOGLOBULIN A; NEPHRITIS; PURPURA; VASCULITIS;

CHILD; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; PROGNOSIS; PURPURA, SCHOENLEIN-HENOCH;

EID: 84890561430     PISSN: 10344810     EISSN: 14401754     Source Type: Journal    
DOI: 10.1111/jpc.12403     Document Type: Review

References (52)

1. Rook A,. William Heberden's cases of anaphylactoid purpura. Arch. Dis. Child. 1958; 33: 271.
2. Schönlein JL,. Allgemeine und Specielle Pathologie und Therapie, Vol. 2, 3rd edn. Wurzburg: Herisau, 1837; 48.
3. Henoch EH,. Über eine eigenthümliche Form von Purpura. Berl. Klin. Wochenschr. 1874; 11: 641-643.
4. Ozen S, Ruperto N, Dillon MJ, et al. EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann. Rheum. Dis. 2006; 65: 936-941.
5. Dolezalová P, Telekesová P, Nemcová D, et al. Incidence of vasculitis in children in the Czech Republic: 2-year prospective epidemiology survey. J. Rheumatol. 2004; 31: 2295-2299.
6. Penny K, Fleming M, Kazmierczak D, et al. An epidemiological study of Henoch-Schönlein purpura. Pediatr. Nurs. 2010; 22: 30-35.
7. Saulsbury ST,. Henoch-Schönlein purpura in children: report of 100 children and review of the literature. Medicine 1999; 78: 395-409.
8. González LM, Janniger CK, Schwartz RA,. Pediatric Henoch-Schönlein purpura. Int. J. Dermatol. 2009; 48: 1157-1165.
9. Weiss PF, Klink AJ, Luan X, Feudtner C,. Temporal association of Streptococcus, Staphylococcus, and parainfluanza pediatric hospitalizations and hospitalized cases of Henoch-Schönlein purpura. J. Rheumatol. 2010; 37: 2587-2594.
10. Watanabe T,. Henoch-Schönlein purpura following influenza vaccinations during the pandemic of influenza A (H1N1). Pediatr. Nephrol. 2011; 25: 795-798.
11. Kiryluk K, Moldoveanu Z, Sanders JT, et al. Aberrant glycosylation of IgA1 is inherited in both pediatric IgA nephropathy and Henoch-Schönlein purpura nephritis. Kidney Int. 2011; 80: 79-87.
12. Sanders JT, Wyatt RJ,. IgA nephropathy and Henoch Schönlein purpura nephritis. Curr. Opin. Pediatr. 2008; 20: 163-170.
13. Kerr MA,. The structure and function of human IgA. Biochem. J. 1990; 271: 285-296.
14. Allen AC, Willis FR, Beattie TJ, et al. Abnormal IgA glycosylation in Henoch-Schönlein purpura restricted to patients with clinical nephritis. Nephrol. Dial. Transplant. 1998; 13: 930-934.
15. Novak J, Julian BA, Tomana M, et al. IgA glycosylation and IgA immune complexes in the pathogenesis of IgA nephropathy. Semin. Nephrol. 2008; 28: 78-87.
16. Trapani S, Micheli A, Grisolia F, et al. Henoch Schonlein purpura in childhood: epidemiological and clinical analysis of 150 cases over a 5-year period and review of literature. Semin. Arthritis Rheum. 2005; 35: 143-153.
17. Choong CK, Beasley SW,. Intra-abdominal manifestations of Henoch-Schönlein purpura. J. Paediatr. Child Health 1998; 34: 405-409.
18. Narchi H,. Risk of long term renal impairment and duration of follow up recommended for Henoch-Schonlein purpura with normal or minimal urinary findings: a systematic review. Arch. Dis. Child. 2005; 90: 916-920.
19. Jauhola O, Ronkainen J, Koskimies O, et al. Renal manifestations of Henoch-Schönlein purpura in a 6-month prospective study of 223 children. Arch. Dis. Child. 2010; 95: 877-882.
20. Belman AL, Leicher CR, Moshé SL, et al. Neurologic manifestations of Schoenlein-Henoch purpura: report of three cases and review of the literature. Pediatrics 1985; 75: 687-692.
21. Ha TS, Lee JS,. Scrotal involvement in childhood Henoch-Schönlein purpura. Acta Paediatr. 2007; 96: 552-555.
22. Vats KR, Vats A, Kim Y, et al. Henoch-Schönlein purpura and pulmonary hemorrhage: a report and literature review. Pediatr. Nephrol. 1999; 13: 530-534.
23. Robson WL, Leung AK, Mathers MS,. Renal colic due to Henoch- Schönlein purpura. J. S. C. Med. Assoc. 1994; 90: 592-595.
24. Ozen S, Pistorio A, Iusan SM, et al. EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II.Final classicication criteria. Ann. Rheum. Dis. 2010; 69: 798-806.
25. Lau KK, Wyatt RJ, Moldoveanu Z, et al. Serum levels of galactose-deficient IgA in children with IgA nephropathy and Henoch-Schönlein purpura. Pediatr. Nephrol. 2007; 22: 2067-2072.
26. Williams H,. Imaging and intussusception. Arch. Dis. Child. Educ. Pract. Ed. 2008; 93: 30-36.
27. Haas M,. IgA nephropathy and Henoch-Schönlein purpura nephritis. In:, Jennette JC, Olson JL, Schwartz MM, Silva FG, eds. Heptinstall's Pathology of the kidney, Vol. 1, 6th edn. Philadelphia: Lippincott Williams & Wilkins, 2007; 423-486.
28. Edström Halling S, Söderberg MP, Berg UB,. Predictors of outcome in Henoch-Schönlein nephritis. Pediatr. Nephrol. 2010; 25: 1101-1108.
29. Davin JC,. Henoch-Schonlein purpura nephritis: pathophysiology, treatment and future strategy. Clin. J. Am. Soc. Nephrol. 2011; 6: 679-689.
30. Szer IS,. Gastrointestinal and renal involvement in vasculitis: management strategies in Henoch-Schönlein purpura. Cleve. Clin. J. Med. 1999; 66: 312-317.
31. Ronkainen J, Koskimies O, Ala-Houhala M, et al. Early prednisone treatment in Henoch-Schönlein purpura: a randomized, double-blind placebo-controlled trial. J. Pediatr. 2006; 149: 241-247.
32. Weiss PF, Feinstein JA, Luan X, et al. Effects of corticosteroid on Henoch-Schönlein purpura: a systematic review. Pediatrics 2007; 120: 1079-1087.
33. Weiss PF, Klink AJ, Localio R, et al. Corticosteroids may improve clinical outcomes during hospitalization for Henoch-Schönlein purpura. Pediatrics 2010; 126: 674-681.
34. Chartapisak W, Opastirakul S, Hodson EM, et al. Interventions for preventing and treating kidney disease in Henoch-Schönlein purpura (HSP). Cochrane Database Syst. Rev. 2009; (8): CD005128.
35. Niaudet P, Habib R,. Methylprednisolone pulse therapy in the treatment of severe forms of Schönlein-Henoch purpura nephritis. Pediatr. Nephrol. 1998; 12: 238-243.
36. Kidney Disease: Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group. KDIGO Clinical Practice Guideline for Glomerulonephritis. Kidney Int. 2012; 2: 139-247. http://kdigo.org/home/glomerulonephritis-gm/ [accessed September 2013].
37. Tarshish P, Bernstein J, Edelmann CM Jr,. Henoch-Schönlein purpura nephritis: course of disease and efficacy of cyclophosphamide. Pediatr. Nephrol. 2004; 19: 51-56.
38. Pillebout E, Alberti C, Guillevin L, et al. Addition of cyclophosphamide to steroids provides no benefit compared with steroids alone in treating adults patients with severe Henoch Schönlein Purpura. Kidney Int. 2010; 78: 495-502.
39. Shenoy M, Ognjanovic MV, Coulthard MG,. Treating severe Henoch-Schönlein and IgA nephritis with plasmapheresis alone. Pediatr. Nephrol. 2007; 22: 1167-1171.
40. Park JM, Won SC, Shin JI, et al. Cyclosporin A therapy for Henoch-Schönlein nephritis with nephrotic range proteinuria. Pediatr. Nephrol. 2011; 26: 411-417.
41. Jauhola O, Ronkainen J, Autio-Harmainen H, et al. Cyclosporine A vs. methylprednisolone for Henoch-Schönlein nephritis: a randomized trial. Pediatr. Nephrol. 2011; 26: 2159-2166.
42. Heldrich FJ, Minkin S, Gatdula CL,. Intravenous immunoglobulin in Henoch-Schönlein purpura: a case study. Md Med. J. 1993; 42: 577-579.
43. Iijima K, Ito-Kariya S, Nakamura H, et al. Multiple combined therapy for severe Henoch-Schönlein purpura nephritis in children. Pediatr. Nephrol. 1998; 12: 244-248.
44. Kanai H, Sawanobori E, Kobayashi A, et al. Early treatment with methylprednisolone pulse therapy combined with tonsillectomy for heavy proteinuric henoch-schönlein purpura nephritis in children. Nephron Extra 2011; 1: 101-111.
45. Donnithorne KJ, Atkinson TP, Hinze CH, et al. Rituximab therapy for severe refractory chronic Henoch-Schönlein purpura. J. Pediatr. 2009; 155: 136-139.
46. Du Y, Hou L, Zhao C, et al. Treatment of children with Henoch-Schönlein purpura nephritis with mycophenolate mofetil. Pediatr. Nephrol. 2012; 27: 765-771.
47. Coppo R, Peruzzi L, Amore A, et al. IgACE: a placebo-controlled, randomized trial of angiotensin-converting enzyme inhibitors in children and young people with IgA nephropathy and moderate proteinuria. J. Am. Soc. Nephrol. 2007; 18: 1880-1888.
48. Schärer K, Krmar R, Querfeld U, et al. Clinical outcome of Schönlein-Henoch purpura nephritis in children. Pediatr. Nephrol. 1999; 13: 816-823.
49. Butani L, Morgenstern BZ,. Long-term outcome in children after Henoch-Schönlein purpura nephritis. Clin. Pediatr. (Phila) 2007; 46: 505-511.
50. Tizard EJ, Hamilton-Ayres MJ,. Henoch Schonlein purpura. Arch. Dis. Child. Educ. Pract. Ed. 2008; 93: 1-8.
51. Thervet E, Aouizerate J, Noel LH, et al. Histologic recurrence of Henoch-Schönlein Purpura nephropathy after renal transplantation on routine allograft biopsy. Transplantation 2011; 92: 907-912.
52. Han SS, Sun HK, Lee JP, et al. Outcome of renal allograft in patients with Henoch-Schönlein nephritis: single-center experience and systematic review. Transplantation 2010; 89: 721-726.